Drawing for GENEA BIOMEDX

USPTO serial 79168866

GENEA BIOMEDX

Reviewed by CopyMark Law Group

Reg. 5093258Status 706Renewal
Filing date
Status date
Registration date
Dec 6, 2016
Examiner
TWOHIG, SHANNON MARIE
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with GENEA BIOMEDX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,950

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Eric Lamb

Eric Lamb FBT Gibbons LLP111 Monument CircleSuite 4500INDIANAPOLIS, IN 46204

Goods and services

ClassDescriptionStatusFirst use
005human cell products, namely, pluripotent and differentiated human cells and stem cells for medical purposes and clinical use, bioassays and cell culture media for use in medical applications; biological and chemical products and substances for medical use, namely, biological and chemical preparations to support growth of human cells and embryos, cell culture media for medical or clinical use, chemical reagents for medical or clinical use; preparations for the diagnosis of pregnancy; preparations for the diagnosis and/or treatment of infertility and other disorders relating to fertility and human reproductionACTIVE—
009Scientific and laboratory apparatus, instruments and equipment, namely, incubators and parts and fittings therefor used to support development of human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, all being for scientific or laboratory use; scientific and laboratory apparatus, instruments and equipment, namely, apparatus, instruments and equipment and parts and fittings therefor for vitrification, cultivation, cryopreservation, warming and thawing of human blastocysts, human reproductive tissue, human sperm, human oocytes or human embryos, all being for scientific or laboratory use; scientific and laboratory apparatus instruments and equipment, namely, equipment for identifying, separating, extracting and processing human sperm or human oocytes, all being for scientific or laboratory use; scientific and laboratory apparatus, instruments and equipment, namely, equipment for monitoring the development, cultivation, cryopreservation, warming or thawing of human, embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, all being for scientific or laboratory use; scientific and laboratory apparatus, instruments and equipment, namely, equipment for storing or preserving human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, all being for scientific or laboratory useACTIVE—
010Surgical and medical apparatus and instruments for use in general surgical or medical procedures; surgical and medical equipment in the nature of incubators and parts and fittings therefor for in vitro fertilization or treatment of infertility and other disorders relating to fertility and human reproduction; surgical and medical equipment in the nature of apparatus, instruments and equipment for vitrification, cultivation, cryopreservation, warming and thawing of human blastocysts, human reproductive tissue, human sperm, human oocytes or human embryos and parts and fittings therefor for surgical or medical purposes; surgical and medical equipment in the nature of equipment for identifying, separating, extracting and processing human sperm or human oocytes and being for surgical or medical purposes; surgical and medical equipment in the nature of equipment for monitoring the development, cultivation or cryopreservation of human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes and being for surgical or medical purposes; surgical and medical equipment in the nature of equipment for storing or preserving human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes and being for surgical or medical purposesACTIVE—
035[ Retail and wholesale store services featuring human cell products, bioassays and cell culture media for use in medical or medical research applications, biological and chemical products and substances for medical use, preparations for the diagnosis of pregnancy, preparations for the diagnosis and/or treatment of infertility and other disorders relating to fertility and human reproduction, scientific apparatus, scientific instruments, scientific equipment, laboratory apparatus, laboratory instruments, laboratory equipment, surgical apparatus, surgical instruments, surgical equipment, medical apparatus, medical instruments, medical equipment, educational materials and programs for use by medical, research or scientific laboratories, clinics and facilities, medical practitioners, doctors, clinicians, hospitals and medical patients ]SECTION 71 - CANCELLED—
042[ Scientific and technological services, namely, scientific research, the fields of reproductive science, human fertility, human reproduction, human genetics, stem cells, assisted conception, reproductive genetics, in vitro fertilisation, fertility management, embryology, andrology, embryo biopsy, genetic diagnosis, immunology, endocrinology, ultrasonology, the development of culture media and media formulations, media evaluation, embryo storage, cell cloning, fertility testing; scientific research and design services in the fields of reproductive science, human fertility, human reproduction, human genetics, stem cells, assisted conception, reproductive genetics, in vitro fertilisation, fertility management, embryology, andrology, embryo biopsy, genetic diagnosis, immunology, endocrinology, ultrasonology, the development of culture media and media formulations, media evaluation, embryo storage, cell cloning, fertility testing; providing information about scientific research in the fields of reproductive science, human fertility, human reproduction, human genetics, stem cells, assisted conception, reproductive genetics, in vitro fertilisation, fertility management, embryology, andrology, embryo biopsy, genetic diagnosis, immunology, endocrinology, ultrasonology, the development of culture media and media formulations, media evaluation, embryo storage, cell cloning, fertility testing; laboratory services, namely, medical laboratories, clinical laboratories and scientific research laboratories in the field of development of culture media and media formulations; providing information in the fields of medical laboratories, clinical laboratories and scientific research laboratories relating to reproductive science, human fertility, human reproduction, human genetics, stem cells, assisted conception, reproductive genetics, in vitro fertilisation, fertility management, embryology, andrology, embryo biopsy, genetic diagnosis, immunology, endocrinology, ultrasonology, media evaluation, embryo storage, cell cloning, fertility testing, the development of culture media and media formulations ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 6, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Nov 6, 202671AGREGISTERED-SEC.71 ACCEPTED—
Nov 2, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 8, 2026ES71TEAS SECTION 71 RECEIVED—
Dec 6, 2025REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
May 29, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Nov 8, 2024INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Oct 9, 2024INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Oct 9, 2024INPCINVALIDATION PROCESSED—
Oct 1, 2024INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 31, 2024NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jan 31, 202471.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Jan 29, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 24, 2023ES71TEAS SECTION 71 RECEIVED—
Jan 7, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 6, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 15, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 18, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 18, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 1, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 10, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 10, 2017FIMPFINAL DISPOSITION PROCESSED—
Mar 6, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 6, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 2, 2016OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 20, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 20, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 31, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 31, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 31, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 11, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 9, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 8, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 8, 2016ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 16, 2016CHLDCHANGE OF OWNER RECEIVED FROM IB—
Feb 24, 2016GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 24, 2016GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 24, 2016CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 20, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 19, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 19, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 19, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 4, 2015RFNTREFUSAL PROCESSED BY IB—
Aug 20, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 20, 2015RFRRREFUSAL PROCESSED BY MPU—
Aug 19, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 18, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 12, 2015DOCKASSIGNED TO EXAMINER—
Jul 21, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 17, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 16, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance